Scott Melzer

Company: Tempus

Job title: Vice President - Business Development & Sequencing

Seminars:

Building a New CDx Ecosystem to Support Early Clinical Development Through Commercial Launch 5:00 pm

Tempus combines RWD offering with CDx development to optimize biomarker design Supporting trial enrollment using design controlled IUO tests Improve speed to market using Tempus FDA-approved xT CDx assay Immediate commercial access to 1000s of oncologists in the US and growing internationallyRead more

day: Day 1 PM